Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)

Fludarabine, cyclophosphamide and rituximab (FCR) was compared to bendamustine and rituximab (BR) in an international, randomized, open label, phase 3 trial in 561 previously untreated, fit patients with chronic lymphocytic leukemia (CLL) without del (17p). Primary endpoint was progression free surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutsch, Nadine, Bahlo, Jasmin, Robrecht, Sandra, Franklin, Jeremy, Zhang, Can, Maurer, Christian, De Silva, Nisha, Lange, Elisabeth, Weide, Rudolf, Kiehl, Michael G., Sökler, Martin, Schlag, Rudolf, Vehling-Kaiser, Ursula, Köchling, Georg, Plöger, Christoph, Gregor, Michael, Plesner, Torben, Herling, Marco, Fischer, Kirsten, Döhner, Hartmut, Kneba, Michael, Wendtner, Clemens-Martin, Klapper, Wolfram, Kreuzer, Karl-Anton, Böttcher, Sebastian, Stilgenbauer, Stephan, Fink, Anna Maria, Hallek, Michael, Eichhorst, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000471/
https://www.ncbi.nlm.nih.gov/pubmed/32072150
http://dx.doi.org/10.1097/HS9.0000000000000336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000471/
https://www.ncbi.nlm.nih.gov/pubmed/32072150
http://dx.doi.org/10.1097/HS9.0000000000000336

Ejemplares similares